MicroRNA-138-5p Suppresses Non-small Cell Lung Cancer Cells by Targeting PD-L1/PD-1 to Regulate Tumor Microenvironment

Increased PD-L1 expression in radioresistant HNSCC cell lines after irradiation affects cell proliferation due to inactivation of GSK-3beta

(2019) Daniela Schulz et al.   Oncotarget

Role of PD-L1 Expression in Non-Small Cell Lung Cancer and Their Prognostic Significance according to Clinicopathological Factors and Diagnostic Markers

(2019) Konrad Pawelczyk et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory

(2019) Mauro Poggio et al.   CELL

Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer

(2018) Jayati Chakrabarti et al.   Oncotarget

MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR

(2017) Jiao Yang et al.   INTERNATIONAL JOURNAL OF CANCER

T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition

(2017) Enfu Hui et al.   SCIENCE

MiR-138: A promising therapeutic target for cancer

(2017) Huan-Huan Sha et al.   TUMOR BIOLOGY

MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling

(2017) Fengzhi Si et al.   Experimental and Therapeutic Medicine

Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma

(2017) Song Xue et al.   Oncotarget

Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma

(2016) Curtis A. Clark et al.   CANCER RESEARCH

MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2

(2016) Baoen Jiang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer

(2016) Lian Zhao et al.   Oncotarget

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

(2015) Suzanne L. Topalian et al.   CANCER CELL

miRNAs in melanoma: a defined role in tumor progression and metastasis

(2015) Francesco Mannavola et al.   Expert Review of Clinical Immunology

MicroRNA-138 regulates the balance of Th1/Th2 via targeting RUNX3 in psoriasis

(2015) Dandan Fu et al.   IMMUNOLOGY LETTERS

Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma

(2015) Yang Wen et al.   INTERNATIONAL JOURNAL OF CANCER

MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C

(2015) Jiefang Li et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma

(2015) Bo Huang et al.   JOURNAL OF SURGICAL RESEARCH

MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints

(2015) Jun Wei et al.   NEURO-ONCOLOGY

miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1

(2015) RAN XU et al.   ONCOLOGY REPORTS

MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3

(2015) Li-ping Han et al.   TUMOR BIOLOGY

MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma

(2015) Fei Ma et al.   PLoS One

miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124

(2014) Yi Gao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening

(2014) Robert A. Smith et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells

(2014) Xian-wei Ye et al.   Clinical Respiratory Journal

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer

(2013) Huijun Zhang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer

(2013) Junquan Yang et al.   PATHOLOGY RESEARCH AND PRACTICE

MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma

(2012) Wen Wang et al.   CARCINOGENESIS

Cancer Mortality Attributable to Tobacco in Asia Based on the WHO Global Report

(2012) K. Saika et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2

(2012) Tadashi Yokosuka et al.   JOURNAL OF EXPERIMENTAL MEDICINE

MicroRNA-138 Modulates DNA Damage Response by Repressing Histone H2AX Expression

(2011) Y. Wang et al.   MOLECULAR CANCER RESEARCH

TGF-β1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4+Foxp3+ regulatory T cells

(2010) Zhijian Cai et al.   Cellular & Molecular Immunology

Tumor-Educated CD11b high Ia low Regulatory Dendritic Cells Suppress T Cell Response through Arginase I

(2009) Qiuyan Liu et al.   JOURNAL OF IMMUNOLOGY

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal

(2009) Brian T Fife et al.   NATURE IMMUNOLOGY

Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance

(2008) S. Xia et al.   BLOOD

Pulmonary stromal cells induce the generation of regulatory DC attenuating T-cell-mediated lung inflammation

(2008) Qian Li et al.   EUROPEAN JOURNAL OF IMMUNOLOGY